参考文献/References:
[1] WANG L,YU W,YIN X,et al.Prevalence of osteoporosis and fracture in China:the China osteoporosis prevalence study[J].JAMA Netw Open,2021,4(8):e2121106.
[2] SI L,WINZENBERG T M,JIANG Q,et al.Projection of osteoporosis-related fractures and costs in China:2010—2050[J].Osteoporos Int,2015,26(7):1929-1937.
[3] 程悦斌,王宝剑,穆乃旗,等.2023版美国医师协会《成人原发性骨质疏松症或低骨量骨折预防的药物治疗临床指南》解读[J].中医正骨,2025,37(5):1-5.
[4] SOFIADIS K,JOSIPOVIC N,NIKOLIC M,et al.HMGB1 coordinates SASP-related chromatin folding and RNA homeostasis on the path to senescence[J].Mol Syst Biol,2021,17(6):e9760.
[5] WANG C Q,HUANG B F,WANG Y,et al.Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis[J].Sci Rep,2020,10(1):18587.
[6] WU Z,ZHU J,WEN Y,et al.Hmga1-overexpressing lentivirus protects against osteoporosis by activating the Wnt/β-catenin pathway in the osteogenic differentiation of BMSCs[J].FASEB J,2023,37(9):e22987.
[7] FENG W,WANG J,YAN X,et al.ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension[J].Cell Prolif,2021,54(6):e13048.
[8] HUANG S E,KUO C H,SHIAO S Y,et al.Soluble CD93 lectin-like domain sequesters HMGB1 to ameliorate inflammatory diseases[J].Theranostics,2023,13(12):4059-4078.
[9] CHEN R,ZOU J,ZHONG X,et al.HMGB1 in the interplay between autophagy and apoptosis in cancer[J].Cancer Lett,2024,581:216494.
[10] QIAO X,LI W,ZHENG Z,et al.Inhibition of the HMGB1/RAGE axis protects against cisplatin-induced ototoxicity via suppression of inflammation and oxidative stress[J].Int J Biol Sci,2024,20(2):784-800.
[11] XU X,PIAO H N,AOSAI F,et al.Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB pathways[J].Br J Pharmacol,2020,177(22):5224-5245.
[12] NIE Z,MIAO H,LI C,et al.Electroacupuncture inhibits the expression of HMGB1/RAGE and alleviates injury to the primary motor cortex in rats with cerebral ischemia[J].Transl Neurosci,2023,14(1):20220316.
[13] YAMASHIRO K,IDEGUCHI H,AOYAGI H,et al.High mobility group box 1 expression in oral inflammation and regeneration[J].Front Immunol,2020,11:1461.
[14] DENG Y,YU L,LAI W,et al.Knocking down macrophages Caspase-6 through HMGB1 coordinates macrophage trophoblast crosstalk to suppress ferroptosis and alleviate preeclampsia[J].Int Immunopharmacol,2024,140:112859.
[15] DAVIS H M,VALDEZ S,GOMEZ L,et al.High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro[J].J Cell Biochem,2019,120(10):16741-16749.
[16] DA'AT ARINA Y M,RUBIANTO M,FERDIANSYAH F,et al.High-mobility group box 1 expression in mandibular bone cells of experimental periodontitis[J].Contemp Clin Dent,2019,10(3):525-530.
[17] OYAMA M,UKAI T,YAMASHITA Y,et al.High-mobility group box 1 released by traumatic occlusion accelerates bone resorption in the root furcation area in mice[J].J Periodontal Res,2021,56(1):186-194.
[18] LEE H G,HUR J,WON J P,et al.Ginseng(Panax ginseng)leaf extract modulates the expression of heme oxyge-nase-1 to attenuate osteoclast differentiation[J].Fitoterapia,2024,173:105831.
[19] LIN Y C,ZHENG G,LIU H T,et al.USP7 promotes the osteoclast differentiation of CD14+ human peripheral blood monocytes in osteoporosis via HMGB1 deubiquitination[J].J Orthop Transl,2023,40:80-91.
[20] HE F,BAI J,WANG J,et al.Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro[J].J Cell Physiol,2019,234(10):17314-17325.
[21] ANLOAGUE A,SABOL H M,KAUR J,et al.A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma[J].Haematologica,2025,110(4):952-966.
[22] BIDWELL J P,YANG J,ROBLING A G.Is HMGB1 an osteocyte alarmin?[J].J Cell Biochem,2008,103(6):1671-1680.
[23] CHEN H,ZHENG Q,LV Y,et al.CUL4A-mediated ZEB1/microRNA-340-5p/HMGB1 axis promotes the development of osteoporosis[J].J Biochem Mol Toxicol,2023,37(8):e23373.
[24] ZHU G,KAN C,CAO C,et al.HMGB1 and TLR4 as biomarkers for osteoporosis risk in type 2 diabetes mellitus:a cross-sectional study[J].BMC Endocr Disord,2025,25(1):175.
[25] LIU B,GAN X,ZHAO Y,et al.Inhibition of HMGB1 reduced high glucose-induced BMSCs apoptosis via activation of AMPK and regulation of mitochondrial functions[J].J Physiol Biochem,2021,77(2):227-235.
[26] LI Q,YU B,YANG P.Hypoxia-induced HMGB1 in would tissues promotes the osteoblast cell proliferation via activating ERK/JNK signaling[J].Int J Clin Exp Med,2015,8(9):15087-15097.
[27] KISHI S,FUJIWARA-TANI R,HONOKI K,et al.Oxidized high mobility group B-1 enhances metastability of colorectal cancer via modification of mesenchymal stem/stromal cells[J].Cancer Sci,2022,113(8):2904-2915.
[28] LIN F,ZHANG W,XUE D,et al.Signaling pathways involved in the effects of HMGB1 on mesenchymal stem cell migration and osteoblastic differentiation[J].Int J Mol Med,2016,37(3):789-797.
[29] XU J Z,ZHOU Y M,ZHANG L L,et al.BMP9 reduces age-related bone loss in mice by inhibiting osteoblast sene-scence through Smad1-Stat1-P21 axis[J].Cell Death Discov,2022,8(1):254.
[30] PAN K,LU Y,CAO D,et al.Long non-coding RNA SNHG1 suppresses the osteogenic differentiation of bone marrow mesenchymal stem cells by binding with HMGB1[J].Biochem Genet,2024,62(4):2869-2883.
[31] KALINKOVICH A,LIVSHITS G.The cross-talk between the cGAS-STING signaling pathway and chronic inflammation in the development of musculoskeletal disorders[J].Ageing Res Rev,2025,104:102602.
[32] YANG H,ANTOINE D J,ANDERSSON U,et al.The many faces of HMGB1:molecular structure-functional activity in inflammation,apoptosis,and chemotaxis[J].J Leukoc Biol,2013,93(6):865-873.
[33] GKOUVERIS I,HADAYA D,ELZAKRA N,et al.Inhibition of HMGB1/RAGE signaling reduces the incidence of medication-related osteonecrosis of the jaw(MRONJ)in mice[J].J Bone Miner Res,2022,37(9):1775-1786.
[34] CHAROONPATRAPONG K,SHAH R,ROBLING A G,et al.HMGB1 expression and release by bone cells[J].J Cell Physiol,2006,207(2):480-490.
[35] HU M,ZHANG Y,LU Y,et al.Regulatory mechanisms of HMGB1 and its receptors in polycystic ovary syndrome-driven gravid uterine inflammation[J].FEBS J,2023,290(7):1874-1906.
[36] PARK J S,GAMBONI-ROBERTSON F,HE Q,et al.High mobility group box 1 protein interacts with multiple Toll-like receptors[J].Am J Physiol Cell Physiol,2006,290(3):C917-C924.
[37] HE Z W,QIN Y H,WANG Z W,et al.HMGB1 acts in sy-nergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways[J].Mediators Inflamm,2013,2013:596716.
[38] HREGGVIDSDOTTIR H S,OSTBERG T,W?H?MAA H,et al.The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation[J].J Leukoc Biol,2009,86(3):655-662.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(09):16.